Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes
Science · 07.02.2025 · 387 (6734) · 674-682
DOI: 10.1126/science.adr4731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 07.02.2025. Verfasst von Haaglim Cho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany. Hauptthemen laut MEDLINE: Adrenomedullin, Diabetes Mellitus, Type 2, Endothelial Cells, Endothelium, Vascular. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 76 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Insulin resistance is a hallmark of obesity-associated type 2 diabetes. Insulin’s actions go beyond metabolic cells and also involve blood vessels, where insulin increases capillary blood flow and delivery of insulin and nutrients. We show that adrenomedullin, whose plasma levels are increased in obese humans and mice, inhibited insulin signaling in human endothelial cells through protein-tyrosine phosphatase 1B–mediated dephosphorylation of the insulin receptor. In obese mice lacking the endothelial adrenomedullin receptor, insulin-induced endothelial nitric oxide–synthase activation and skeletal muscle perfusion were increased. Treating mice with adrenomedullin mimicked the effect of obesity and induced endothelial and systemic insulin resistance. Endothelial loss or blockade of the adrenomedullin receptor improved obesity-induced insulin resistance. These findings identify a mechanism underlying obesity-induced systemic insulin resistance and suggest approaches to treat obesity-associated type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Max Planck Institute for Heart and Lung Research, Department of Pharmacology, Bad Nauheim, Germany.
- Department of Cardiovascular Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Max Planck Institute for Heart and Lung Research, Biomolecular Mass Spectrometry, Bad Nauheim, Germany.
- Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
- Oncology Area, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain.
- Max Planck Institute for Heart and Lung Research, Bioinformatics, Bad Nauheim, Germany.
ORCID-Profile: Haaglim Cho, Chien-Cheng Lai, Rémy Bonnavion, Mohamad Wessam Alnouri, ShengPeng Wang, Haruya Kawase, Lee S Weinstein, Alfredo Martínez, Mario Looso, Miloslav Sanda, Stefan Offermanns
Zitieren
APA
Cho, H., Lai, C. C., Bonnavion, R., Alnouri, M. W., Wang, S., Roquid, K. A., Kawase, H., Campos, D., Chen, M., Weinstein, L. S., Martínez, A., Looso, M., Sanda, M., & Offermanns, S. (2025). Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. Science, 387(6734), 674-682. https://doi.org/10.1126/science.adr4731
Vancouver
Cho H, Lai CC, Bonnavion R, Alnouri MW, Wang S, Roquid KA, et al. Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes. Science. 2025;387(6734):674-682. doi:10.1126/science.adr4731
BibTeX
@article{Cho2025,
author = {Cho, Haaglim and Lai, Chien-Cheng and Bonnavion, Rémy and Alnouri, Mohamad Wessam and Wang, ShengPeng and Roquid, Kenneth Anthony and Kawase, Haruya and Campos, Diana and Chen, Min and Weinstein, Lee S and Martínez, Alfredo and Looso, Mario and Sanda, Miloslav and Offermanns, Stefan},
title = {Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes},
journal = {Science},
year = {2025},
volume = {387},
number = {6734},
pages = {674--682},
doi = {10.1126/science.adr4731}
}
EUVIMED